GE HealthCare

GE HealthCare (Nasdaq: GEHC) has appointed William “Bill” Grogan as chief financial officer, effective Sept. 14, 2026, bringing in an experienced finance executive from Xylem as the medical technology company advances its precision care strategy. Grogan succeeds Jay Saccaro, who previously announced his departure to take an expanded role outside the medical technology industry. George Newcomb, currently serving as interim CFO, will continue as GE HealthCare’s controller and chief accounting officer. , a global water solutions company with approximately $9 billion in revenue, where he has served as executive vice president and CFO since 2023.

During his tenure at Xylem, Grogan worked with the company’s leadership team on a strategy focused on accelerating growth, expanding margins and simplifying operations. Those efforts helped direct investment toward innovation as well as higher-growth digital and services businesses. 5 billion acquisition, with Xylem delivering cost synergies ahead of schedule. His responsibilities included portfolio optimization and capital deployment across the company. “I am excited that Bill will serve as our CFO and help lead our next chapter of growth,” GE HealthCare President and CEO Peter Arduini said.

” Before joining Xylem, Grogan spent more than a decade at IDEX Corporation, a global engineered products company serving a range of specialized markets. He was IDEX’s senior vice president and chief financial officer from 2017 until 2023. As CFO at IDEX, Grogan helped shift the company’s portfolio toward higher-growth markets while maintaining a focus on margin expansion and disciplined capital allocation. During that period, the company’s market capitalization more than doubled. His earlier career included finance leadership positions at Walgreens, Crane Co.

, giving him experience across industrial, retail and diversified corporate environments. At GE HealthCare, Grogan will take responsibility for the finance organization as the company works to translate investment in medical technology and precision care into profitable growth. His experience managing acquisitions, portfolio strategy and capital deployment could be particularly relevant as GE HealthCare balances investment in innovation with its financial and shareholder objectives.